Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jihoon, Choi, Min-Koo, Song, Im-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301446/
https://www.ncbi.nlm.nih.gov/pubmed/37375753
http://dx.doi.org/10.3390/ph16060802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301446/
https://www.ncbi.nlm.nih.gov/pubmed/37375753
http://dx.doi.org/10.3390/ph16060802

Ejemplares similares